SK282844B6 - Vodná kompozícia na nazálne podanie desmopresínu - Google Patents

Vodná kompozícia na nazálne podanie desmopresínu Download PDF

Info

Publication number
SK282844B6
SK282844B6 SK1650-95A SK165095A SK282844B6 SK 282844 B6 SK282844 B6 SK 282844B6 SK 165095 A SK165095 A SK 165095A SK 282844 B6 SK282844 B6 SK 282844B6
Authority
SK
Slovakia
Prior art keywords
composition
desmopressin
buffer
nasal
preservative
Prior art date
Application number
SK1650-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK165095A3 (en
Inventor
Alan Harris
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of SK165095A3 publication Critical patent/SK165095A3/sk
Publication of SK282844B6 publication Critical patent/SK282844B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SK1650-95A 1993-06-29 1994-06-22 Vodná kompozícia na nazálne podanie desmopresínu SK282844B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8489493A 1993-06-29 1993-06-29
PCT/SE1994/000623 WO1995001183A1 (fr) 1993-06-29 1994-06-22 Compositions permettant l'administration par voie nasale de desmopressine

Publications (2)

Publication Number Publication Date
SK165095A3 SK165095A3 (en) 1996-11-06
SK282844B6 true SK282844B6 (sk) 2002-12-03

Family

ID=22187889

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1650-95A SK282844B6 (sk) 1993-06-29 1994-06-22 Vodná kompozícia na nazálne podanie desmopresínu

Country Status (20)

Country Link
US (1) US5498598A (fr)
EP (1) EP0708657B1 (fr)
JP (1) JPH09502425A (fr)
KR (1) KR100193104B1 (fr)
CN (1) CN1101701C (fr)
AT (1) ATE203412T1 (fr)
CA (1) CA2166312C (fr)
CZ (1) CZ282456B6 (fr)
DE (1) DE69427820T2 (fr)
DK (1) DK0708657T3 (fr)
ES (1) ES2158898T3 (fr)
GR (1) GR3036936T3 (fr)
HK (1) HK1000906A1 (fr)
HU (1) HU221617B1 (fr)
NZ (1) NZ268442A (fr)
PL (1) PL176317B1 (fr)
PT (1) PT708657E (fr)
RU (1) RU2135204C1 (fr)
SK (1) SK282844B6 (fr)
WO (1) WO1995001183A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT710243E (pt) * 1993-06-29 2000-11-30 Ferring Bv Sintese melhorada de peptidos ciclicos.
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5916582A (en) * 1996-07-03 1999-06-29 Alza Corporation Aqueous formulations of peptides
GB9614235D0 (en) * 1996-07-06 1996-09-04 Danbiosyst Uk Composition for enhanced uptake of polar drugs from mucosal surfaces
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
JP2001233787A (ja) 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
US6641799B2 (en) 2002-04-03 2003-11-04 Nos Spray, Inc. Nasal spray for decongesting nasal passages
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003097080A1 (fr) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited Composition aqueuse stable de peptide
ATE324869T1 (de) * 2003-11-13 2006-06-15 Ferring Bv Blisterverpackung und feste dosierungsform enthaltend desmopressin
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
KR101522747B1 (ko) 2007-08-06 2015-05-26 알레간 인코포레이티드 데스모프레신 약물 전달을 위한 방법 및 장치
CN101372504B (zh) * 2007-08-22 2011-05-18 深圳翰宇药业股份有限公司 一种纯化去氨加压素的方法
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
PT2712622T (pt) 2008-05-21 2016-10-13 Ferring Bv Desmopressina orodispersível para aumentar o período inicial de sono tranquilo
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
ES2692345T5 (es) * 2008-12-22 2024-01-26 Acerus Pharmaceuticals Usa Llc Administración intranasal de desmopresina
US20100160214A1 (en) * 2008-12-22 2010-06-24 Serenity Pharmaceuticals Corporation Desmopressin composition
AU2015261630B2 (en) * 2008-12-22 2017-09-14 Acerus Pharmaceuticals USA, LLC Intranasal desmopressin administration
ES2969281T3 (es) 2009-06-18 2024-05-17 Acerus Pharmaceuticals Usa Llc Administración segura de desmopresina
CN102440957B (zh) * 2011-12-16 2013-09-25 深圳市健元医药科技有限公司 醋酸特利加压素鼻腔喷雾剂及其制备方法
ES2761776T3 (es) 2014-12-22 2020-05-21 Suda Pharmaceuticals Ltd Prevención y tratamiento de la enfermedad metastásica en pacientes con cáncer trombocitótico
WO2024105521A1 (fr) * 2022-11-17 2024-05-23 Shilpa Medicare Limited Composition pharmaceutique peptidique stable

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
EP0300036A4 (fr) * 1987-01-30 1989-06-14 Biomed Res Consultants Ltd Compositions pharmaceutiques a base de vasopressine.
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
ATE108326T1 (de) * 1989-01-30 1994-07-15 Corint Ltd Wässerige desmopressin-cmc enthaltende arzneizubereitung.
ES2067624T3 (es) * 1989-11-16 1995-04-01 Ph & T S R L Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal.

Also Published As

Publication number Publication date
EP0708657B1 (fr) 2001-07-25
CN1126439A (zh) 1996-07-10
CZ282456B6 (cs) 1997-07-16
US5498598A (en) 1996-03-12
HK1000906A1 (en) 2002-03-08
HUT73776A (en) 1996-09-30
NZ268442A (en) 1996-09-25
ES2158898T3 (es) 2001-09-16
EP0708657A1 (fr) 1996-05-01
RU2135204C1 (ru) 1999-08-27
CN1101701C (zh) 2003-02-19
GR3036936T3 (en) 2002-01-31
CA2166312C (fr) 2002-04-23
HU221617B1 (hu) 2002-12-28
ATE203412T1 (de) 2001-08-15
PT708657E (pt) 2001-11-30
DE69427820T2 (de) 2001-11-08
WO1995001183A1 (fr) 1995-01-12
KR100193104B1 (ko) 1999-06-15
PL312204A1 (en) 1996-04-01
DK0708657T3 (da) 2001-10-15
HU9503833D0 (en) 1996-02-28
PL176317B1 (pl) 1999-05-31
CZ339095A3 (en) 1996-09-11
KR960703339A (ko) 1996-08-17
JPH09502425A (ja) 1997-03-11
SK165095A3 (en) 1996-11-06
DE69427820D1 (de) 2001-08-30
CA2166312A1 (fr) 1995-01-12

Similar Documents

Publication Publication Date Title
SK282844B6 (sk) Vodná kompozícia na nazálne podanie desmopresínu
EP0710122B1 (fr) Compositions pharmaceutiques peptidiques stabilisees
US5902789A (en) Nasal administration of drugs
AU707527B2 (en) Nasal administration of desmopressin
USRE43580E1 (en) Nasal calcitonin formulations
HU223316B1 (hu) Flutikaszon-propionátot tartalmazó gyógyászati készítmények
IE60259B1 (en) "Aqueous steroid formulations for nasal administration"
US7378082B1 (en) Method for treating allergic rhinitis without adverse effects
WO2004014411A1 (fr) Formulation pharmaceutique contenant un peptide nasal
EA024475B1 (ru) Композиции витамина в12 для интраназального применения
MXPA97000440A (en) Pharmaceutical composition nasod administrable monodosis and method of application of such composic

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20110622